JPH03227933A - Vasodepressor and anti-vasopressor agent - Google Patents

Vasodepressor and anti-vasopressor agent

Info

Publication number
JPH03227933A
JPH03227933A JP2019247A JP1924790A JPH03227933A JP H03227933 A JPH03227933 A JP H03227933A JP 2019247 A JP2019247 A JP 2019247A JP 1924790 A JP1924790 A JP 1924790A JP H03227933 A JPH03227933 A JP H03227933A
Authority
JP
Japan
Prior art keywords
hemicellulose
bran
derived
viscosity
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019247A
Other languages
Japanese (ja)
Other versions
JP2780201B2 (en
Inventor
Toshiaki Kodama
俊明 児玉
Kiwamu Shiiba
究 椎葉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Priority to JP2019247A priority Critical patent/JP2780201B2/en
Publication of JPH03227933A publication Critical patent/JPH03227933A/en
Application granted granted Critical
Publication of JP2780201B2 publication Critical patent/JP2780201B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To provide the subject vasodepressor and anti-vasopressor agent composed of a bran-derived hemicelullose hydrolysate having a specified viscosity, showing a vasodepressor activity and an anti-vasopressor activity by a very small-quantity administration and ready to handle and take in. CONSTITUTION:A white and water soluble powdery vasodepressor and anti- vasopressor agent composed of a bran-derived hemicelullose hydrolysate 5wt.% aqueous solution of which is 5-30 centipoise, preferably especially about 5-20 centipoise at 25 deg.C in measurement by using an Ostwald's viscometer and ready to handle because of its low viscosity even in a high-concentration solution such as 5wt.% solution, capable of a large-amount administrate in a form of a high-concentration solution at a time therefor, capable of administration in a form of solid also without further processing and having a vasodepressor and anti-vasopressor activity equal to or higher than that of unhydrolyzed hemicelullose.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は血圧降下および上昇抑制剤に関する。[Detailed description of the invention] [Industrial application field] TECHNICAL FIELD The present invention relates to an agent for lowering and suppressing blood pressure increase.

[従来の技術1 近年、成人病の予防、コレステロールの低下および上昇
抑制作用、整腸作用、大腸ガンの予防等の点から食物繊
維(ダイエタリーファイバー)の有効性が再認識されて
おり、それに伴って食物繊維の積極的な摂取が種々試み
られるようになった。そして、そのような試みの例とし
ては、(1)これまで主に家畜用飼料として用いられで
きた米糠や小麦フスマの利用や、(行)グアガム、ロー
カストビーンガム、タラガム、トラガガントガム等のガ
ム類、コンニャクマンナン等の難消化性多糖類の利用等
が挙げられる。
[Prior art 1] In recent years, the effectiveness of dietary fiber has been re-recognized in terms of preventing adult diseases, lowering and suppressing cholesterol rise, regulating the intestines, and preventing colon cancer. As a result, various attempts have been made to actively intake dietary fiber. Examples of such attempts include (1) the use of rice bran and wheat bran, which have so far been mainly used as livestock feed, and (row) the use of gums such as guar gum, locust bean gum, tara gum, and tragaganth gum. , use of indigestible polysaccharides such as konjac mannan, etc.

しかしながら、上記(i)の場合には米糠や小麦フスマ
を多量に摂取しないと効果がなく、食感の劣悪な米糠や
小麦フスマを多量に摂取することは事実上困難であった
。そこで、その改良技術として、米糠や小麦フスマ等に
含有されている食物繊維を回収してそれを利用する方法
があり、特公昭62−6691号公報および特開昭63
216822号公報等には、米糠や小麦フスマ等からヘ
ミセルロースを抽出し、これを血清コレステロール、中
性脂肪、肝臓コレステロールの上昇抑制物質として利用
することが記載されている。
However, in the case of (i) above, there is no effect unless a large amount of rice bran or wheat bran is ingested, and it is practically difficult to ingest a large amount of rice bran or wheat bran, which have poor texture. Therefore, as an improvement technique, there is a method of recovering the dietary fiber contained in rice bran, wheat bran, etc. and utilizing it.
Publication No. 216822 and the like describes that hemicellulose is extracted from rice bran, wheat bran, etc. and used as a substance for suppressing the rise in serum cholesterol, neutral fat, and liver cholesterol.

しかしながら、そこで抽出したヘミセルロースの溶液は
粘度が高くて取扱いにくいものでありIこ 。
However, the extracted hemicellulose solution has a high viscosity and is difficult to handle.

また、上記(ii)の場合も、ガム類やコンニャクマン
ナン等の難消化性多糖類はそのままでは嗜好性に劣り摂
取しにくいため水溶液等にして利用されること多いが、
その水溶液は嗜好性および取扱性の劣る粘稠な高粘度溶
液であり、そのために1%以下の低濃度水溶液にせざる
を得ない。しかしながら、低濃度水溶液にすると目的量
の食物繊維を摂取するのに多量の水溶液を摂取しなけれ
ばならず、事実上食物繊維の多量摂取が困難であった。
Also, in the case of (ii) above, indigestible polysaccharides such as gums and konjac mannan are often used in aqueous solutions because they are less palatable and difficult to ingest as they are.
The aqueous solution is a highly viscous solution with poor palatability and ease of handling, and therefore has to be made into a low concentration aqueous solution of 1% or less. However, if a low concentration aqueous solution is used, a large amount of the aqueous solution must be ingested in order to ingest the desired amount of dietary fiber, and it is actually difficult to ingest a large amount of dietary fiber.

そして、かかる従来技術(■)の欠点の解消法として、
上記難消化性多糖類を植物繊維組織崩壊酵素により部分
加水分解し、その結果得られた加水分解物の1%水溶液
が10mPa−8以下になるように調製して、それを食
物繊維として使用することが報告されている(特開昭6
3−269993号公報)。この場合に、その加水分解
物の1%水溶液は確かにlomPa−3以下の低い粘度
を示すが、高濃度水溶液(例えば5%水溶液)にすると
粘度が極めて高くなって取扱性および食感が大幅に低下
するため高濃度溶液での使用が困難になり、食物繊維の
必要量の摂取の妨げになっていた。その上、そこではガ
ム類等の難消化性多糖類の主鎖が主として加水分解切断
されるために得られた加水分解物は分解前のものよりも
分子量がかなり小さくなっており食物繊維としての機能
も大幅に劣ったものになっていた。
As a solution to the drawbacks of the prior art (■),
Partially hydrolyze the above indigestible polysaccharide with a plant fiber tissue disintegrating enzyme, prepare a 1% aqueous solution of the resulting hydrolyzate to have a pressure of 10 mPa-8 or less, and use it as dietary fiber. It has been reported that
3-269993). In this case, a 1% aqueous solution of the hydrolyzate certainly exhibits a low viscosity of lomPa-3 or less, but if it is made into a highly concentrated aqueous solution (for example, a 5% aqueous solution), the viscosity becomes extremely high and the handling and texture are greatly affected. This makes it difficult to use high-concentration solutions and hinders intake of the required amount of dietary fiber. Furthermore, because the main chain of indigestible polysaccharides such as gums is mainly hydrolyzed and cleaved there, the resulting hydrolyzate has a much smaller molecular weight than the one before decomposition, and can be used as dietary fiber. Its functionality was also significantly inferior.

[発明の内容] 本発明者等はフスマ由来のヘミセルロースの物性改良や
有効利用について研究を行ってきた。
[Contents of the Invention] The present inventors have conducted research on improving the physical properties and effective utilization of hemicellulose derived from bran.

その結果、フスマ由来のヘミセルロースを部分加水分解
して得られた加水分解物は、5%という高濃度水溶液に
した場合にも低い粘度を示し取扱い易く且つ摂取し易い
こと、しかもその加水分解物の分子量は加水分解前のヘ
ミセルロースの分子量に比べてさほど低下しておらず、
血清コレステロール、中性脂肪および肝臓コレステロー
ルの上昇抑制作用の外に、血圧降下作用および血圧上昇
抑制作用を有することを見出した。本発明のかかる発見
は、コレステロールや中性脂肪の上昇抑制剤が直ちに血
圧降下および血圧上昇抑制作用を示さないという従来の
知一 見からすると全く予想外のことである。
As a result, the hydrolyzate obtained by partially hydrolyzing hemicellulose derived from bran showed a low viscosity even when made into a high concentration aqueous solution of 5%, and was easy to handle and ingest. The molecular weight is not significantly lower than that of hemicellulose before hydrolysis.
It has been found that in addition to suppressing the rise in serum cholesterol, triglyceride and liver cholesterol, it has a blood pressure lowering effect and a blood pressure rise suppressing effect. This discovery of the present invention is completely unexpected in view of the conventional knowledge that agents that suppress increases in cholesterol and triglycerides do not immediately lower blood pressure or suppress increases in blood pressure.

したがって、本発明は、フスマ由来ヘミセルロース加水
分解物であって、その5%水溶液の粘度がオストワルド
粘度計を用いて25℃で測定したときに5〜30センチ
ポワズであるフスマ由来ヘミセルロース加水分解物から
なる血圧降下および上昇抑制剤である。
Therefore, the present invention is a bran-derived hemicellulose hydrolyzate, which comprises a bran-derived hemicellulose hydrolyzate, the viscosity of which in a 5% aqueous solution is 5 to 30 centipoise when measured at 25°C using an Ostwald viscometer. It is a blood pressure lowering and increasing suppressant.

本発明で使用する「フスマ由来ヘミセルロース加水分解
物」は、その5%水溶液の粘度がオストワルド粘度計を
用いて25℃で測定したときに5〜30センチボワズ(
以下rcPJという)であることが必要であり、5%水
溶液の粘度が5cPより低いと血圧降下および上昇抑制
剤としての機能が低下または失われる。また5%水溶液
の粘度が30cPより高いと粘度が高すぎて摂取しにく
くなり、取扱性も劣る。摂取のし易さ、取扱性等の点か
ら、5%水溶液の粘度が特に約5〜20cPであるのが
好ましい。
The "bran-derived hemicellulose hydrolyzate" used in the present invention has a viscosity of 5 to 30 centiboise (
(hereinafter referred to as rcPJ), and if the viscosity of the 5% aqueous solution is lower than 5 cP, the function as a blood pressure lowering and increase suppressing agent will be reduced or lost. Furthermore, if the viscosity of the 5% aqueous solution is higher than 30 cP, the viscosity will be too high, making it difficult to ingest, and the handling properties will be poor. From the viewpoint of ease of ingestion, ease of handling, etc., it is particularly preferable that the viscosity of the 5% aqueous solution is about 5 to 20 cP.

本発明で使用するフスマ由来ヘミセルロース加水分解物
は、例えば本出願人自身の出願に係る特願平1−163
849号に記載されているように、小麦、大麦、カラス
麦、ライ麦、エン麦等の麦類のフスマをアルカリで抽出
処理して得られるフスマ由来ヘミセルロースを酵素、酸
、アルカリ等によって部分加水分解処理することにより
調製することができる。
The bran-derived hemicellulose hydrolyzate used in the present invention is disclosed in, for example, Japanese Patent Application No. 1-169 filed by the present applicant.
As described in No. 849, hemicellulose derived from wheat bran obtained by extracting wheat bran from wheat, barley, oats, rye, oats, etc. with alkali is partially hydrolyzed with enzymes, acids, alkalis, etc. It can be prepared by processing.

そのうちでも、酵素による部分加水分解処理が、過度の
加水分解または加水分解不足等を伴わず、温和な榮件下
で目的とする粘度を示す加水分解物を効率良く精製し得
るので好ましい。
Among these, partial hydrolysis treatment using an enzyme is preferable because it can efficiently purify a hydrolyzate exhibiting a desired viscosity under mild conditions without causing excessive hydrolysis or insufficient hydrolysis.

フスマ由来ヘミセルロースを部分加水分解するための酵
素としては、ヘミセルラーゼ(例えばヤクルト社製の“
オノズカ″、寄進製薬社製のペクトリアーゼ)、セルラ
ーゼ等の植物繊維組織崩壊酵素が使用できる。その際に
酵素は遊離の状態で使用しても担体に固定化して使用し
てもよい。また部分加水分解処理は連続法で行ってもバ
ッチ法で行ってもよい。フスマ由来ヘミセルロースの種
類、酵素を遊離の状態で使用するかまたは固定化して使
用するか、連続法で行うかまたはバッチ法で行うか等に
応じて酵素の種類、その使用量、部分加水分解時の温度
、圧力、pH,時間等を選択して部分加水分解を行うと
よい。その場合に酵素の使用量が多いほど加水分解物を
短時間で生成させることができるが、その量が多すぎる
と血圧降下および上昇抑制剤としての機能を持たない単
糖やオリゴ糖等の、平均分子量が約1000以下の低分
子物質が生成するので望ましくない。例えば、小麦フス
マ由来のヘミセルロースを上記ヤクルト社製のパオノズ
カ″を使用して部分加水分解する場合は、小麦フスマ由
来ヘミセルロースの約1〜5重量%水溶液(pH約3.
5〜7.0)を調製し、この水溶液に約1〜50ppm
(w/v)の“′オノズカ″を加えて約40〜60℃の
温度で約5分〜1時間加水分解すると目的とする加水分
解物を得ることができる。この加水分解反応において、
フスマ由来ヘミセルロース水溶液の粘度が当初急激に低
下しその後は徐々に低下してゆくが、急激な粘度低下が
終了した時点で加水分解反応を停止さ一 せることにより、粘度が低いにも拘らず平均分子量の大
幅な低下のない血圧降下および上昇抑制剤としての機能
を保持した分子量の高いフスマ由来ヘミセルロース加水
分解物を得ることができる。急激な粘度低下が終了した
後も加水分解反応を継続すると、粘度低下はあまり進ま
ないかヘミセルロース加水分解物の分子量が低下してゆ
き目的物が得られない。この場合の「急激な粘度低下が
終了した時点」とは、急激な粘度低下が止まって緩やか
な粘度低下へと移行する時点とそれから30分以内の間
の時点をいう。
Enzymes for partially hydrolyzing hemicellulose derived from bran include hemicellulase (for example, “
Plant fiber tissue-disintegrating enzymes such as "Onozuka", pectolyase manufactured by Donishin Seiyaku Co., Ltd.), and cellulase can be used. In this case, the enzyme may be used in a free state or immobilized on a carrier. Also, partially hydrated The decomposition treatment may be carried out in a continuous or batch method.The type of hemicellulose derived from bran, whether the enzyme is used in a free state or immobilized, and it is carried out in a continuous or batch method. It is best to perform partial hydrolysis by selecting the type of enzyme, the amount used, temperature, pressure, pH, time, etc. during partial hydrolysis depending on the situation. can be produced in a short time, but if the amount is too large, low-molecular substances with an average molecular weight of about 1000 or less, such as monosaccharides and oligosaccharides, which do not have the function of lowering or suppressing blood pressure increase, are produced. For example, when partially hydrolyzing hemicellulose derived from wheat bran using the above-mentioned "Paonozuka" manufactured by Yakult, an approximately 1 to 5% by weight aqueous solution of hemicellulose derived from wheat bran (pH approximately 3.
5 to 7.0) and add about 1 to 50 ppm to this aqueous solution.
The desired hydrolyzate can be obtained by adding (w/v) "Onozuka" and hydrolyzing it at a temperature of about 40 to 60°C for about 5 minutes to 1 hour. In this hydrolysis reaction,
The viscosity of the bran-derived hemicellulose aqueous solution initially decreases rapidly and then gradually decreases, but by stopping the hydrolysis reaction once the rapid viscosity decrease has finished, the average viscosity can be reduced even though the viscosity is low. It is possible to obtain a bran-derived hemicellulose hydrolyzate having a high molecular weight and retaining its functions as a blood pressure lowering and blood pressure increase suppressing agent without significantly lowering the molecular weight. If the hydrolysis reaction is continued even after the rapid viscosity decrease has ended, the viscosity decrease will not proceed much or the molecular weight of the hemicellulose hydrolyzate will decrease, making it impossible to obtain the desired product. In this case, "the point at which the rapid viscosity decrease ends" refers to a point within 30 minutes from the point at which the rapid viscosity decrease stops and shifts to a gradual viscosity decrease.

そして、例えば小麦フスマ由来ヘミセルロースについて
みると、加水分解前にはその5%水溶液の25℃におけ
るブルックフィールド粘度が通常約150〜180cP
であるのに対して、本発明で使用する加水分解物のそれ
は上記のように5〜30cPであり、加水分解により粘
度が極めて低くなっていることがわかる。
For example, when looking at hemicellulose derived from wheat bran, the Brookfield viscosity of a 5% aqueous solution at 25°C is usually about 150 to 180 cP before hydrolysis.
In contrast, the viscosity of the hydrolyzate used in the present invention is 5 to 30 cP as mentioned above, indicating that the viscosity is extremely low due to hydrolysis.

また、本発明で使用するフスマ由来ヘミセルロース加水
分解物は、後記の方法によってその− 平均分子量を測定したときに、通常、その約70重量%
以上が約70万〜150万の平均分子量の範囲にあり、
一方、加水分解前のフスマ由来ヘミセルロースではその
約85〜95重量%が、通常、約70万〜150万の平
均分子量の範囲にあるから、両者を対比すると、本発明
で使用する加水分解物はその5%水溶液の粘度が極めて
低く保たれるにも拘らず、その平均分子量が加水分解前
のフスマ由来ヘミセルロースの平均分子量とさして変わ
らないことがわかる。
In addition, the wheat bran-derived hemicellulose hydrolyzate used in the present invention usually has an average molecular weight of about 70% by weight when its average molecular weight is measured by the method described below.
The average molecular weight is in the range of about 700,000 to 1,500,000,
On the other hand, about 85-95% by weight of bran-derived hemicellulose before hydrolysis usually has an average molecular weight in the range of about 700,000 to 1,500,000, so comparing the two, the hydrolyzate used in the present invention is It can be seen that although the viscosity of the 5% aqueous solution is kept extremely low, its average molecular weight is not much different from the average molecular weight of the bran-derived hemicellulose before hydrolysis.

しかしながら、上で説明したフスマ由来ヘミセルロース
加水分解物の調製法は一例であって、本発明の剤は上記
により調製されたものに限定されるものではない。本発
明では、フスマ由来ヘミセルロースの加水分解物であっ
て、それを5%水溶液にしたときの粘度が上記した5〜
30cPの範囲内にあるものであればいずれも使用でき
、その調製法は問わない。
However, the method for preparing the bran-derived hemicellulose hydrolyzate described above is only one example, and the agent of the present invention is not limited to that prepared as described above. In the present invention, a hydrolyzate of hemicellulose derived from bran is used, which has a viscosity of 5 to 5% when made into a 5% aqueous solution.
Any material within the range of 30 cP can be used, and its preparation method is not limited.

本発明のフスマ由来ヘミセルロース加水分解物からなる
血圧降下および上昇抑制剤は、水溶性の白色粉末であっ
て、これを人間および種々の動物(例えば、犬、ネコ等
のペット類)に少量投与することによって、高血圧症の
人間や動物の血圧を降下させることができ、更に血圧の
上昇を抑制することができる。
The antihypertensive and antihypertensive agent of the present invention comprising a hemicellulose hydrolyzate derived from bran is a water-soluble white powder that is administered in small amounts to humans and various animals (for example, pets such as dogs and cats). By doing so, it is possible to lower the blood pressure of hypertensive humans and animals, and furthermore it is possible to suppress the increase in blood pressure.

また、本発明の血圧降下および上昇抑制剤は、フスマ由
来ヘミセルロース加水分解物とともに、血圧降下や血圧
上昇抑制に関与することが知られているカリウムを含有
することができ、カリウムの併用によって血圧降下およ
び血圧上昇抑制効果が一層増進される。この場合のカリ
ウムは、塩化カリウム、炭酸カリウム、リン酸カリウム
等の無機カリウム塩または有機カリウム塩の形で使用す
るのがよい。
In addition, the agent for lowering and suppressing blood pressure increase of the present invention can contain potassium, which is known to be involved in lowering blood pressure and suppressing increase in blood pressure, together with bran-derived hemicellulose hydrolyzate, and the combination of potassium can lower blood pressure. and the effect of suppressing the rise in blood pressure is further enhanced. Potassium in this case is preferably used in the form of an inorganic potassium salt such as potassium chloride, potassium carbonate, potassium phosphate, or an organic potassium salt.

本発明の血圧降下および上昇抑制剤の好適な投与量は、
投与される人間や動物の年令、体重、性別、症状、動物
の種類等の種々の条件によって当然具なるが、例えば、
人間であれば体重1kg当たり1日に約0.O1〜0.
5gの割合で、また動物の場合、体重1kg当たり1日
に約0.1〜Logの割合で投与することができる。
The preferred dosage of the antihypertensive and antihypertensive agent of the present invention is as follows:
This naturally depends on various conditions such as the age, weight, sex, symptoms, and type of animal of the human or animal being administered, but for example,
For humans, it is approximately 0.00 kg per kg of body weight per day. O1~0.
It can be administered at a rate of 5 g and in animals at a rate of about 0.1 to Log per kg body weight per day.

そして、本発明の血圧降下および上昇抑制剤は、経口投
与によって投与する。更に、本発明の血圧降下および上
昇抑制剤は、単独で投与しても、また製薬工業において
通常使用されている固体担体や液状担体と一緒に投与し
てもよく、或は他の薬剤と混合して、または組合わせて
使用することができる。その投与形態は、錠剤、丸剤、
顆粒剤、カプセル、散剤、水溶液等の任意の形態で使用
可能である。
The agent for lowering and suppressing blood pressure increase of the present invention is administered orally. Furthermore, the antihypertensive and antihypertensive agents of the present invention may be administered alone, together with solid carriers or liquid carriers commonly used in the pharmaceutical industry, or mixed with other drugs. Can be used alone or in combination. Its dosage forms include tablets, pills,
It can be used in any form such as granules, capsules, powders, and aqueous solutions.

更に、本発明の血圧降下および上昇抑制剤は、食品や飼
料中に添加して、またはそれらと−緒に投与することが
できる。
Furthermore, the agent for lowering and suppressing blood pressure increase of the present invention can be added to or administered together with foods and feeds.

以下に、本発明を例を挙げて具体的に説明するが本発明
はそれらによって限定されない。下記の例中の%は総て
重量による。
The present invention will be specifically explained below by giving examples, but the present invention is not limited thereto. All percentages in the examples below are by weight.

また、下記の例中ならびに上記したフスマ由来ヘミセル
ロースおよびその加水分解物の平均分子量は次のように
して測定した。
In addition, the average molecular weights of the bran-derived hemicellulose and its hydrolyzate in the following examples and above were measured as follows.

[平均分子量の測定法コ 精製すれたヘミセルロースまたはその加水分解物を超純
水に溶かして1%水溶液を形成する。
[Method for Measuring Average Molecular Weight] Purified hemicellulose or its hydrolyzate is dissolved in ultrapure water to form a 1% aqueous solution.

その水溶液を20μg採取して80℃に保温された高速
液体クロマトグラフィー分離カラム(ウルトラハイドロ
ジェル1000 :米国Waters社製)に注入し、
そこに超純水からなる溶出液を流速0.5m12/分で
流して、溶出液(超純水)の屈折率とカラムからの流出
液の屈折率との差である示差屈折率をチャートとして経
時的に測定記録し Iこ 。
20 μg of the aqueous solution was collected and injected into a high performance liquid chromatography separation column (Ultra Hydrogel 1000: manufactured by Waters, USA) kept at 80°C.
An eluent consisting of ultrapure water was flowed there at a flow rate of 0.5 m12/min, and the differential refractive index, which is the difference between the refractive index of the eluate (ultrapure water) and the refractive index of the effluent from the column, was plotted as a chart. Measurements are recorded over time.

一方、平均分子量が既知のプルランを5種類用意しく平
均分子量が2万〜150万の間のもの)、上記と同様に
して分離カラムから流出させてその示差屈折率のチャー
1・を経時的に記録し、該チャートに表れた各々の平均
分子量のプルランに相当する5つのピークの現出時間と
平均分子量との関係から検量線を作成し標準とした。
On the other hand, prepare five types of pullulans with known average molecular weights (with average molecular weights between 20,000 and 1,500,000), flow them out of the separation column in the same manner as above, and measure the differential refractive index of Char 1 over time. A calibration curve was prepared from the relationship between the average molecular weight and the appearance time of five peaks corresponding to pullulan of each average molecular weight appearing on the chart and used as a standard.

ヘミセルロースまたはその加水分解物の流出に伴う示差
屈折率を経時的に記録した上記の1 チャートにおけるピークの現出時間を上記標準検量線と
照合してヘミセルロースおよびその加水分解物の平均分
子量を求めた。
The average molecular weight of hemicellulose and its hydrolyzate was determined by comparing the appearance time of the peak in the above-mentioned 1 chart, in which the differential refractive index accompanying the outflow of hemicellulose or its hydrolyzate was recorded over time, with the standard calibration curve described above. .

参考例 1 [小麦フスマ由来ヘミセルロースの調製1精選小麦フス
マ2kgを50℃の温水20Ωに分散させ5分間撹拌す
る。その後遠心濾過機(田辺鉄工新製)で濾過して固形
分を回収し、得られた固形分3kgを7060,0.2
N水酸化ナトリウム水溶液204に入れ、90分間撹拌
する。放冷後、0.8N塩酸水溶液5aを撹拌下に徐々
に加えて中和する。中和溶液を5 、000 Gで10
分間遠心分離する。その上澄み液を分取し、全糖量が5
mg/mQになるように水で希釈し、液温50℃に保温
する。全溶液を管状限外濾過膜(日東電工i : NT
U3520−PI3型、膜面積0−76m”、内径11
.5mm)の管内を通し、圧力8kg/am”、流速1
3 Q / m i nの条件下で3時間処理する。こ
の時、膜透過溶液と同量の水を常に管内に補給し膜処理
液量を定とする。3時間後水の供給を止め、前記と同2 様の条件で濃縮を開始しフラックスの低下を考慮するこ
となく濃縮を行い、水溶液の糖濃度が約10 m g 
/ m Qになるまで約1.5時間行う。処理液をオル
ガノ社製陽イオン交換樹脂IR−120E 500cc
に1時間当たりイオン交樹脂換容量の10倍の流速で溶
出し、次いで同社製の陰イオン交換樹脂IRA−93に
同流速で流す。イオン交換処理後、得られた水溶液を真
空凍結乾燥しく温度30℃1真空度0.1Torr以下
)、白色のヘミセルロース粉末を得た(精選小麦フスマ
に対する回収率ニア、5%)。
Reference Example 1 [Preparation of wheat bran-derived hemicellulose 1 2 kg of selected wheat bran is dispersed in 20Ω of 50°C warm water and stirred for 5 minutes. After that, the solid content was collected by filtration with a centrifugal filter (manufactured by Tanabe Iron Works), and the obtained solid content was 7060,0.2 kg.
Add to N aqueous sodium hydroxide solution 204 and stir for 90 minutes. After cooling, 0.8N hydrochloric acid aqueous solution 5a is gradually added under stirring to neutralize. Neutralizing solution at 5,000 G for 10
Centrifuge for minutes. The supernatant liquid was separated and the total sugar content was 5.
Dilute with water to a concentration of mg/mQ, and keep the solution at a temperature of 50°C. The entire solution was passed through a tubular ultrafiltration membrane (Nitto Denko i: NT
U3520-PI3 type, membrane area 0-76m”, inner diameter 11
.. 5mm) at a pressure of 8kg/am” and a flow rate of 1
Treat for 3 hours under conditions of 3 Q/min. At this time, the same amount of water as the membrane permeation solution is constantly replenished into the tube to keep the membrane treatment liquid volume constant. After 3 hours, the water supply was stopped, and concentration was started under the same conditions as described above.Concentration was performed without considering the decrease in flux, and the sugar concentration of the aqueous solution was approximately 10 mg.
/ m Continue for about 1.5 hours until Q. The treatment liquid was 500cc of cation exchange resin IR-120E manufactured by Organo.
The sample was eluted at a flow rate of 10 times the exchange capacity of the ion exchange resin per hour, and then passed through an anion exchange resin IRA-93 manufactured by the same company at the same flow rate. After the ion exchange treatment, the resulting aqueous solution was freeze-dried in vacuum at a temperature of 30° C. and a vacuum of 0.1 Torr or less) to obtain a white hemicellulose powder (recovery rate near selected wheat bran, 5%).

得られた生成物は25℃の水に完全に溶解した(水不溶
分0%)。また、該生成物中の各成分の含有量および全
糖量の内訳は以下の表−1に示すとおりであった。
The obtained product was completely dissolved in water at 25°C (0% water-insoluble content). Further, the content of each component and the breakdown of the total sugar content in the product were as shown in Table 1 below.

[表−1] 成分含有量 灰  分 (%) 全窒素(%) 全糖量(%) 0.12 4.8 93.6 合  計 (%)            100.0
上記の表−1中、全糖量は下記のようにして求めた。糖
分中の各構成成分(キシロース、アラビノース、グルコ
ース等)の含有量は参考例で最終的に得られた生成物を
TARIO,BHATTI等の方法[Biochim、
 Biophys、 Acta、、 222 (197
0)+339〜347]により加水分解した後メチル化
し、これをガスクロマトグラフィーを使用して分析する
ことにより求めた。表中の値は全て乾物として換算した
値である。
[Table-1] Component content Ash (%) Total nitrogen (%) Total sugar content (%) 0.12 4.8 93.6 Total (%) 100.0
In Table 1 above, the total sugar content was determined as follows. The content of each constituent component (xylose, arabinose, glucose, etc.) in the sugar was determined by the method of TARIO, BHATTI, etc. [Biochim,
Biophys, Acta, 222 (197
0)+339-347], followed by methylation, and the resulting product was analyzed using gas chromatography. All values in the table are calculated as dry matter.

[全糖量の測定法] 糖類を含有する水溶液を蒸留水で100倍に希釈する。[Method for measuring total sugar content] The aqueous solution containing sugars is diluted 100 times with distilled water.

次にこの希釈された水溶液0 、5mQに5%フェノー
ル水溶液0.5mρを添加して撹拌した後濃硫酸3m4
を加えて更に撹拌した。そのまま20分間放置して空冷
した後、波長490nmの吸光度を測定する。測定値を
キシロースを基質とした標準曲線に照合して全糖量を求
めた。
Next, 0.5mρ of a 5% phenol aqueous solution was added to 0.5mQ of this diluted aqueous solution and stirred, followed by 3m4 of concentrated sulfuric acid.
was added and further stirred. After leaving it as it is for 20 minutes and cooling it in the air, absorbance at a wavelength of 490 nm is measured. The total sugar content was determined by comparing the measured values with a standard curve using xylose as a substrate.

参考例 2 [小麦フスマ由来ヘミセルロース部分加水分解物の調製
] 上記の参考例1で調製されたヘミセルロース5gを酢酸
塩緩衝水溶液(酢酸塩含有量50ミリモル、pH5,5
) 100mffに溶解してヘミセルロースの5%水溶
液を調製した(A液)。
Reference Example 2 [Preparation of partial hydrolyzate of hemicellulose derived from wheat bran] 5 g of the hemicellulose prepared in Reference Example 1 above was added to an acetate buffer aqueous solution (acetate content: 50 mmol, pH 5.5).
) A 5% aqueous solution of hemicellulose was prepared by dissolving it in 100 mff (liquid A).

このA液の粘度をオストワルド粘度計を使用して25℃
で測定したところ182cPであった。
The viscosity of this A liquid was measured at 25°C using an Ostwald viscometer.
When measured, it was 182 cP.

次いで、上記のA液を予め40℃で10分間加温した後
、植物繊維組織崩壊酵素゛′オノズカ″(ヤクルト社製
)を25cPg添加し、同温度に保って6 ヘミセルロースの部分加水分解を行わせ、その粘度を上
記と同様にして経時的に測定したところ、図に示した結
果を得た。
Next, after preheating the above solution A at 40°C for 10 minutes, 25 cPg of plant fiber tissue disintegrating enzyme "Onozuka" (manufactured by Yakult Co., Ltd.) was added and kept at the same temperature to partially hydrolyze hemicellulose. When the viscosity was measured over time in the same manner as above, the results shown in the figure were obtained.

図の結果から、液の粘度は加水分解開始後30分までは
急激に低下し、その以後は徐々にしか低下しないことが
わかる。すなわち、ここでは、加水分解開始後約30〜
60分の間が急激な粘度低下が終了する時点に相当する
From the results shown in the figure, it can be seen that the viscosity of the liquid decreases rapidly until 30 minutes after the start of hydrolysis, and then decreases only gradually. That is, here, about 30 to 30 minutes after the start of hydrolysis
The period of 60 minutes corresponds to the point at which the rapid viscosity decrease ends.

そして、上記の加水分解処理において、液の急激な粘度
低下が生じなくなった時点(約30分)から30分後、
すなわち加水分解開始後60分−の時点で加水分解液の
1部(B液)を採取してその粘度を同様にして測定した
ところ25cPであった。
In the above hydrolysis treatment, 30 minutes after the point at which rapid viscosity reduction of the liquid no longer occurs (approximately 30 minutes),
That is, 60 minutes after the start of hydrolysis, a portion of the hydrolysis solution (liquid B) was sampled and its viscosity was measured in the same manner and found to be 25 cP.

更に、加水分解開始後120分後の液の1部(C液)を
採取してその粘度を同様にして測定したところlo、5
cPであった。
Furthermore, when a part of the liquid (liquid C) was collected 120 minutes after the start of hydrolysis and its viscosity was measured in the same manner, lo, 5.
It was cP.

また、上記A液中に含まれる加水分解前のヘミセルロー
スの平均分子量並びにB液およびC液中に含まれるヘミ
セルロース加水分解物の平均分子量を上記した方法によ
って測定したところ、 下記の表 2に示すとおりであった。
In addition, the average molecular weight of the hemicellulose before hydrolysis contained in the above liquid A and the average molecular weight of the hemicellulose hydrolyzate contained in liquids B and C were measured by the above method, and as shown in Table 2 below. Met.

[表−2] 液 93% B液 89% C液 51% 上記の結果から、この参考例2で得られた小麦フスマ由
来ヘミセルロース加水分解物(すなわちB液)は、加水
分解前のヘミセルロース(A液)に比べて粘度が大幅に
低下しているにも拘らず平均分子量の低下が少ないこと
がわかる。また急激な加水分解の終了後も加水分解を停
止させずに継続した場合(C液)には粘度はそれ以上あ
まり低下しないが平均分子量が大幅に低下することがわ
かる。
[Table 2] Solution 93% Solution B 89% Solution C 51% From the above results, the wheat bran-derived hemicellulose hydrolyzate obtained in Reference Example 2 (i.e. Solution B) has a high concentration of hemicellulose (A) before hydrolysis. It can be seen that although the viscosity is significantly lower than that of the liquid), the decrease in the average molecular weight is small. Furthermore, it can be seen that when the hydrolysis is continued without stopping even after the rapid hydrolysis has ended (Liquid C), the viscosity does not decrease much further, but the average molecular weight decreases significantly.

実  施  例 下記の表−3に示した組成からなる試験食A〜Cを準備
した。
Example Test foods A to C having the compositions shown in Table 3 below were prepared.

[表 3] カゼイン(%) L−メチオニン(%) ミネラルミックス(%) ビタミンミックス(%) ショ糖(%) ラード(%) 食  塩(%) 合  計(%)     100     100  
  100*参考例2のB液中に含まれるヘミセルロー
ス加水分解物なお、上記試験食AおよびBでは、試験食
中における食物繊維含有量が3%になるように、参考例
1の未加水分解ヘミセルロースおよび参考例2の加水分
解ヘミセルロースの各々を配合している。
[Table 3] Casein (%) L-methionine (%) Mineral mix (%) Vitamin mix (%) Sucrose (%) Lard (%) Salt (%) Total (%) 100 100
100 * Hemicellulose hydrolyzate contained in Solution B of Reference Example 2 In the above test meals A and B, the unhydrolyzed hemicellulose of Reference Example 1 was added so that the dietary fiber content in the test meals was 3%. and the hydrolyzed hemicellulose of Reference Example 2.

次いで、高血圧自然発症ラット(雄、15週令)を各群
6匹ずつ3群用意した。
Next, three groups of spontaneously hypertensive rats (male, 15 weeks old) with 6 rats in each group were prepared.

各群のラットに対して、上記の試験食A−Cの各々を6
日間自由に摂取させた。
Each group of rats received 6 doses of each of the above test meals A-C.
They were allowed to take it ad libitum for days.

各群のラットの当初と6日後の血圧、および当初と6日
後の平均体重を測定したところ下記の表−4に示すとお
りであった。
The blood pressures of the rats in each group were measured at the beginning and after 6 days, and the average body weights at the beginning and after 6 days were as shown in Table 4 below.

[表−4] 血圧(mmHg) 当  初       203±7.7  203±8
.6  203±11.96日後    184±14
.0 189±16.9 204±12.3平均体重(
g/匹) 当  初       268±8.1  277±4
.8  280±7.56日後    269±6.2
 279±5.3 285±7.5上記表−4の結果か
ら、未加水分解ヘミセルロースおよび加水分解ヘミセル
ロースのいずれ9 をも含有しない試験食Cを投与した群のラットでは血圧
がほとんど降下し゛ていないのに対して、未加水分解ヘ
ミセルロースおよび加水分解ヘミセルロースを含有する
試験食AおよびBを投与した群のラットでは血圧が降下
しており、特に加水分解ヘミセルロースを含有する試験
食Aを投与した群のラットでは血圧の降下が大きいこと
がわかる。
[Table-4] Blood pressure (mmHg) Initially 203±7.7 203±8
.. 6 203±11.96 days later 184±14
.. 0 189±16.9 204±12.3 Average body weight (
g/mouse) Initially 268±8.1 277±4
.. 8 280±7.56 days later 269±6.2
279 ± 5.3 285 ± 7.5 From the results in Table 4 above, the blood pressure of rats in the group administered test food C, which did not contain either unhydrolyzed hemicellulose or hydrolyzed hemicellulose, hardly decreased. On the other hand, the blood pressure of rats in the groups administered test meals A and B containing unhydrolyzed hemicellulose and hydrolyzed hemicellulose decreased, especially in the group administered test meal A containing hydrolyzed hemicellulose. It can be seen that there is a large drop in blood pressure in rats.

[発明の効果] 本発明のフスマ由来加水分解ヘミセルロースからなる血
圧降下および上昇抑制剤は、極めて少量の投与で血圧降
下作用および血圧上昇抑制作用を奏することができ、し
かもかかる血圧降下および上昇抑制作用は、非加水分解
ヘミセルロースと同等以上である。
[Effects of the Invention] The agent for lowering and suppressing blood pressure increase made of hydrolyzed hemicellulose derived from wheat bran of the present invention can exert a blood pressure lowering effect and suppressing effect on blood pressure increase with an extremely small amount of administration. is equivalent to or higher than that of non-hydrolyzed hemicellulose.

また、本発明のフスマ由来ヘミセルロース加水分解から
なる血圧降下および上昇抑制剤は、白色の水溶性粉末で
あって、高濃度の水溶液(例えば5%水溶液)にした場
合でも低い粘度を示し取り扱い易いので、高濃度溶液に
して一度0− に多量に投与することができ、またそのまま固体状で投
与することもできる。
In addition, the agent for lowering and suppressing blood pressure increase made of hydrolyzed hemicellulose derived from wheat bran of the present invention is a white water-soluble powder that exhibits low viscosity even when made into a highly concentrated aqueous solution (for example, a 5% aqueous solution) and is easy to handle. It can be made into a highly concentrated solution and administered in a large amount to 0-, or it can be administered as it is in solid form.

【図面の簡単な説明】[Brief explanation of drawings]

添付図面は、小麦フスマ由来ヘミセルロースを酵素を用
いて部分加水分解処理した場合の加水分解処理時間と粘
度変化との関係を示した図である。
The attached drawing is a diagram showing the relationship between hydrolysis treatment time and viscosity change when wheat bran-derived hemicellulose is partially hydrolyzed using an enzyme.

Claims (1)

【特許請求の範囲】[Claims] フスマ由来ヘミセルロース加水分解物であって、その5
%水溶液の粘度がオストワルド粘度計を用いて25℃で
測定したときに5〜30センチポワズであるフスマ由来
ヘミセルロース加水分解物からなる血圧降下および上昇
抑制剤。
Hemicellulose hydrolyzate derived from bran, part 5
A blood pressure lowering and increasing suppressant comprising a bran-derived hemicellulose hydrolyzate, the viscosity of which is an aqueous solution of 5 to 30 centipoise when measured at 25°C using an Ostwald viscometer.
JP2019247A 1990-01-31 1990-01-31 Antihypertensive and antihypertensive Expired - Lifetime JP2780201B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019247A JP2780201B2 (en) 1990-01-31 1990-01-31 Antihypertensive and antihypertensive

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019247A JP2780201B2 (en) 1990-01-31 1990-01-31 Antihypertensive and antihypertensive

Publications (2)

Publication Number Publication Date
JPH03227933A true JPH03227933A (en) 1991-10-08
JP2780201B2 JP2780201B2 (en) 1998-07-30

Family

ID=11994084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019247A Expired - Lifetime JP2780201B2 (en) 1990-01-31 1990-01-31 Antihypertensive and antihypertensive

Country Status (1)

Country Link
JP (1) JP2780201B2 (en)

Also Published As

Publication number Publication date
JP2780201B2 (en) 1998-07-30

Similar Documents

Publication Publication Date Title
EP2007817B1 (en) Compositions of water soluble beta-glucans
KR0181312B1 (en) Food composite for performing function of large bowl regulation
JPH0745521B2 (en) Antihypertensive agent having antihypertensive effect
JP3195937B2 (en) Method for obtaining amylase inhibitor
JPH0678367B2 (en) Dietary fiber, method for producing the same, and bioactive agent containing the dietary fiber
JPH0728695B2 (en) Food composition having effect of improving serum lipid component
JP2639726B2 (en) Water-soluble dietary fiber and method for producing the same
JP2787252B2 (en) Colorectal cancer inhibitor
JPH03244364A (en) Food composition effective in suppressing secretion of insulin
JP3043888B2 (en) Colorectal cancer prophylactic agent containing glucomannan partial hydrolyzate as active ingredient
JPH02100695A (en) Production of indigestible dextrin
KR100243525B1 (en) Process for producing non-digestive dextrin
JPH082270B2 (en) Method for producing dextrin containing dietary fiber
JPH03227933A (en) Vasodepressor and anti-vasopressor agent
JPH0723315B2 (en) Blood sugar elevation inhibitor
JP2000344802A (en) Blood phosphorus concentration depressant
CN114015737A (en) Preparation method and application of corn glutamine peptide with intestinal barrier protection function
EP0637592B1 (en) Processes of producing amylase inhibitors
JP3191956B2 (en) Alcoholic fatty liver inhibitors
US5444046A (en) Amylase inhibitors
KR100473445B1 (en) cholesterol reducer and health food containing chitosan and ε-polylysine
JP4232461B2 (en) Atopic dermatitis improving agent
JP2804587B2 (en) Antihypertensive / elevation inhibitor and production method thereof
WO2008001770A1 (en) Antiallergic composition and agent, and food, beverage and animal feed each containing the composition or agent
JP2006518190A (en) Method for producing salt containing chitosan having blood pressure lowering function

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080515

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090515

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090515

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100515

Year of fee payment: 12

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100515

Year of fee payment: 12